Within tumorigenesis, VEGF-A has been best characterized, and it is considered to be a strong prognostic marker for glioblastoma aggressiveness, given that patients with the highest circulating levels of VEGF-A have the worst overall survival [84,85]. Here, VEGFA is linked to glioblastoma.